[go: up one dir, main page]

HK1042483B - 四氫噻唑的製造方法 - Google Patents

四氫噻唑的製造方法 Download PDF

Info

Publication number
HK1042483B
HK1042483B HK02103306.1A HK02103306A HK1042483B HK 1042483 B HK1042483 B HK 1042483B HK 02103306 A HK02103306 A HK 02103306A HK 1042483 B HK1042483 B HK 1042483B
Authority
HK
Hong Kong
Prior art keywords
salts
thiazolidin
formula
production
reaction
Prior art date
Application number
HK02103306.1A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1042483A1 (zh
Inventor
Demuth Hans-Ulrich
Kruber Susanne
Original Assignee
Prosidion Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prosidion Limited filed Critical Prosidion Limited
Publication of HK1042483A1 publication Critical patent/HK1042483A1/zh
Publication of HK1042483B publication Critical patent/HK1042483B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK02103306.1A 1999-06-10 2000-04-11 四氫噻唑的製造方法 HK1042483B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19926233.0 1999-06-10
DE19926233A DE19926233C1 (de) 1999-06-10 1999-06-10 Verfahren zur Herstellung von Thiazolidin
PCT/EP2000/003213 WO2000076986A1 (de) 1999-06-10 2000-04-11 Verfahren zur herstellung von thiazolidin

Publications (2)

Publication Number Publication Date
HK1042483A1 HK1042483A1 (zh) 2002-08-16
HK1042483B true HK1042483B (zh) 2004-09-10

Family

ID=7910641

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103306.1A HK1042483B (zh) 1999-06-10 2000-04-11 四氫噻唑的製造方法

Country Status (18)

Country Link
US (1) US6559314B2 (zh)
EP (1) EP1185520B1 (zh)
JP (1) JP3803292B2 (zh)
KR (1) KR100467898B1 (zh)
CN (1) CN1169799C (zh)
AT (1) ATE261946T1 (zh)
AU (1) AU758605B2 (zh)
BR (1) BR0011445A (zh)
CA (1) CA2373834C (zh)
DE (2) DE19926233C1 (zh)
DK (1) DK1185520T3 (zh)
ES (1) ES2215045T3 (zh)
HK (1) HK1042483B (zh)
MX (1) MXPA01012237A (zh)
NZ (1) NZ515561A (zh)
PT (1) PT1185520E (zh)
RU (1) RU2218336C2 (zh)
WO (1) WO2000076986A1 (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2304206A1 (en) * 1997-09-29 1999-04-08 Point Therapeutics, Inc. Stimulation of hematopoietic cells in vitro
US6979697B1 (en) * 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
US6890904B1 (en) * 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
US7550590B2 (en) 2003-03-25 2009-06-23 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EP1625122A1 (en) 2003-05-14 2006-02-15 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
ZA200602051B (en) 2003-08-13 2007-10-31 Takeda Pharmaceutical 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EP1699777B1 (en) 2003-09-08 2012-12-12 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
BRPI0418639B8 (pt) 2004-03-15 2021-05-25 Takeda Pharmaceutical compostos inibidores de dipeptidil peptidase, assim como composição farmacêutica contendo os mesmos
US7687638B2 (en) * 2004-06-04 2010-03-30 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
CN101087756B (zh) * 2004-07-23 2011-04-06 纽阿达有限责任公司 肽酶抑制剂
US20060063719A1 (en) * 2004-09-21 2006-03-23 Point Therapeutics, Inc. Methods for treating diabetes
WO2006068978A2 (en) 2004-12-21 2006-06-29 Takeda Pharmaceutial Company Limited Dipeptidyl peptidase inhibitors
US20070060529A1 (en) * 2005-09-14 2007-03-15 Christopher Ronald J Administration of dipeptidyl peptidase inhibitors
HRP20140091T4 (hr) * 2005-09-14 2021-12-24 Takeda Pharmaceutical Company Limited Davanje inhibitora dipeptidil peptidaze
ZA200802857B (en) 2005-09-14 2009-09-30 Takeda Pharmaceutical Dipeptidyl peptidase inhibitors for treating diabetes
TW200745080A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
TW200745079A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
CN101360723A (zh) 2005-09-16 2009-02-04 武田药品工业株式会社 制备嘧啶二酮衍生物的方法
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US8460362B2 (en) * 2006-07-20 2013-06-11 Orbusneich Medical, Inc. Bioabsorbable polymeric medical device
BRPI0716971A2 (pt) * 2006-09-13 2013-10-15 Takeda Pharmaceutical Uso de 2-6(3-amino-piperini-l-il)-3-metil-2,4-dioxo-3,4-dihidro-2 h-pirimidin-1ilmetil-4-fluoro-benxonitrila
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
CN104910128A (zh) * 2015-06-02 2015-09-16 安徽兴东化工有限公司 一种2,2-二甲基四氢噻唑的制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2961377A (en) 1957-08-05 1960-11-22 Us Vitamin Pharm Corp Oral anti-diabetic compositions and methods
US3594377A (en) * 1967-11-07 1971-07-20 Uniroyal Inc Condensation products of n - (3 -thiazolidinylmethyl) - nitrogen base compounds
DE2009743A1 (de) 1970-03-03 1971-09-16 Farbenfabriken Bayer Ag, 5090 Leverkusen Substituierte Biguanide mit antihyperglykämischer Wirkung
US3960949A (en) 1971-04-02 1976-06-01 Schering Aktiengesellschaft 1,2-Biguanides
CH590857A5 (en) * 1973-05-30 1977-08-31 Givaudan & Cie Sa Substd. thiazolidine odourants flavourants - having a wide aroma spectrum and usable in small concns.
CH602612A5 (zh) 1974-10-11 1978-07-31 Hoffmann La Roche
ATE15668T1 (de) * 1980-12-12 1985-10-15 Fine Organics Ltd Verfahren zur herstellung von thiazolidinderivaten.
US4935493A (en) 1987-10-06 1990-06-19 E. I. Du Pont De Nemours And Company Protease inhibitors
JPH01272570A (ja) * 1988-04-26 1989-10-31 Nippon Shokubai Kagaku Kogyo Co Ltd 4−メチル−5−[(2−アミノエチル)−チオメチル]−イミダゾールの製法
US5433955A (en) 1989-01-23 1995-07-18 Akzo N.V. Site specific in vivo activation of therapeutic drugs
JPH04334357A (ja) 1991-05-02 1992-11-20 Fujirebio Inc 酵素阻害作用を有するアシル誘導体
ES2153831T3 (es) 1991-10-22 2001-03-16 New England Medical Center Inc Inhibidores de dipeptidil-aminopeptidasa de tipo iv.
NO302471B1 (no) * 1991-12-26 1998-03-09 Sankyo Co Tiazolidinforbindelser og farmasöytisk preparat
IL106998A0 (en) 1992-09-17 1993-12-28 Univ Florida Brain-enhanced delivery of neuroactive peptides by sequential metabolism
FR2696740B1 (fr) 1992-10-13 1994-12-30 Dospharma Sa Dérivés prodrogués de la diméthylbiguanide et applications comme médicaments.
WO1995011689A1 (en) 1993-10-29 1995-05-04 Trustees Of Tufts College Use of inhibitors of dipeptidyl-aminopeptidase to block entry of hiv into cells
IL111785A0 (en) 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
US5543396A (en) 1994-04-28 1996-08-06 Georgia Tech Research Corp. Proline phosphonate derivatives
DE4427569A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Verfahren zur Herstellung von Cyanimino-1,3-thiazolidin
US5512549A (en) 1994-10-18 1996-04-30 Eli Lilly And Company Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
US5614379A (en) 1995-04-26 1997-03-25 Eli Lilly And Company Process for preparing anti-obesity protein
DE122010000020I1 (de) 1996-04-25 2010-07-08 Prosidion Ltd Verfahren zur Senkung des Blutglukosespiegels in Säugern
AU3224997A (en) 1996-05-29 1998-01-05 Prototek, Inc Prodrugs of thalidomide and methods for using same as modulators of t-cell function
US6006753A (en) 1996-08-30 1999-12-28 Eli Lilly And Company Use of GLP-1 or analogs to abolish catabolic changes after surgery
AR016751A1 (es) 1996-11-22 2001-08-01 Athena Neurosciences Inc Metodo para inhibir la liberacion del peptido beta-amiloide en una celula, composicion farmaceutica y compuestos utiles en dicho metodo
WO2000001849A1 (en) 1998-07-02 2000-01-13 Invitro Diagnostics, Inc. Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule
AU3960400A (en) 1999-03-05 2000-09-28 Molteni L. E C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv
WO2001062266A2 (en) 2000-02-25 2001-08-30 Novo Nordisk A/S Use of dpp-iv inhibitors for the treatment of diabetes

Also Published As

Publication number Publication date
DE50005699D1 (de) 2004-04-22
DE19926233C1 (de) 2000-10-19
KR100467898B1 (ko) 2005-02-21
CN1169799C (zh) 2004-10-06
HK1042483A1 (zh) 2002-08-16
CA2373834A1 (en) 2000-12-21
BR0011445A (pt) 2002-03-19
RU2218336C2 (ru) 2003-12-10
PT1185520E (pt) 2004-08-31
AU758605B2 (en) 2003-03-27
CN1355795A (zh) 2002-06-26
ES2215045T3 (es) 2004-10-01
ATE261946T1 (de) 2004-04-15
JP3803292B2 (ja) 2006-08-02
EP1185520A1 (de) 2002-03-13
KR20020022688A (ko) 2002-03-27
DK1185520T3 (da) 2004-06-28
JP2003502319A (ja) 2003-01-21
US20020082427A1 (en) 2002-06-27
EP1185520B1 (de) 2004-03-17
US6559314B2 (en) 2003-05-06
AU4399600A (en) 2001-01-02
WO2000076986A1 (de) 2000-12-21
NZ515561A (en) 2003-06-30
CA2373834C (en) 2005-11-08
MXPA01012237A (es) 2002-08-12

Similar Documents

Publication Publication Date Title
HK1042483B (zh) 四氫噻唑的製造方法
MC1199A1 (fr) Composes tricycliques
IL29569A (en) 1,4-dihydropyridine derivatives and their production
SK282736B6 (sk) Spôsob prípravy amlodipín benzénsulfonátu
US4127671A (en) P-acetamidophenyl diethylaminoacetate
JPS60126284A (ja) ピリドンカルボン酸誘導体およびその塩
JPH0587064B2 (zh)
FI63568C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara i 7-staellning substituerade 8-aminometylisoflavonderivat
JPH0215067A (ja) イソキノリンスルホンアミド誘導体
US4609659A (en) 2,6-disubstituted derivatives of 3-nitropyrazines useful as adjuncts to radiation therapy
JPH0573754B2 (zh)
US4317914A (en) Oxazolines
HU198473B (en) Process for producing 8-thiotetrahydro-quinoline derivatives and salts thereof, as well as pharmaceutical compositions comprising same as active ingredient
JPS6310955B2 (zh)
PL144481B1 (en) Process for preparing derivatives of pyrimidinotrione
US3998820A (en) 10'-[ω-N-/1,4-diazabicyclo(4,m,o)-alkanyl/-acyl]-phenothiazines, their acidic addition salts and quaternary salts, process for producing same and use
US3714166A (en) Cocarboxylase arginate and process for the production thereof
DK142172B (da) Analogifremgangsmaade til fremstilling af basisk substituerede2-alkylamino-4-phenylimidazoliner eller syreadditionssalte heraf
JPS59141565A (ja) 向精神性活性を有するピリダジン誘導体,その製造方法および該誘導体を含有する薬剤
US4083976A (en) 10'-( ω-N)-1,4-Diazabicyclo(4,3,0)-alkanyl-lacyl) -phenothiazine compositions
JPH0324077A (ja) イミダゾール誘導体の製法
KR850000431B1 (ko) 피롤 유도체의 제조방법
JPS63165368A (ja) 新規複素環化合物およびその製造法
JPH01216980A (ja) アルキル―ピペラジニル―5,6―アルキレンピリミジン類
KR840001286B1 (ko) 2-이미다졸린 유도체류의 제조방법

Legal Events

Date Code Title Description
PF Patent in force
CHRG Changes in the register

Free format text: FROM PROBIODRUG AG TO PROSIDION LIMITED; JOURNAL NO.: 106; PUBLICATION DATE: 15-04-2005; SECTION NAME: CHANGES IN THE REGISTER 266/280

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130411